Neurogene Inc. (NGNE)
Neurogene Max Pain By Strike
NGNE trades at $19.99, 14.2% above the near-term max pain of $17.5 expiring Sep 19, 2025 (25 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$20), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.
Neurogene Max Pain By Expiry
Max pain for NGNE shows a downward trend from 20 to 2.5, indicating bearish sentiment or hedging activity. The 130% spread signals divergent expectations across timeframes. Most levels below 19.99 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 17.5 | -2.49 (-12.46%) |
| Oct 17, 2025 | 2.5 | -17.49 (-87.49%) |
| Dec 19, 2025 | 20 | 0.01 (0.05%) |
| Mar 20, 2026 | 12.5 | -7.49 (-37.47%) |
| Jan 15, 2027 | 15 | -4.99 (-24.96%) |